EGFR and non-small cell lung carcinoma: Therefore, we used the pairs of patient-derived NSCLC cell lines with the same primary EGFR mutation to dissect the T790M-specific pathways, which may better reflect the heterogeneity of EGFR resistance mutations and patient phenotypes.